Arch Therapeutics, Inc. filed its 10-K on Dec 28, 2022 for the period ending Sep 30, 2022. In this report its auditor, Baker Tilly, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.04 USD | 0.00% | +9.47% | -85.64% |
1st Jan change | Capi. | |
---|---|---|
-85.64% | 4.62M | |
+8.29% | 124B | |
-4.96% | 11.17B | |
+4.83% | 9.17B | |
-22.04% | 4.71B | |
+8.39% | 3.44B | |
-6.28% | 2.88B | |
-10.23% | 2.11B | |
-5.99% | 2.09B | |
-22.62% | 1.8B |
- Stock Market
- Equities
- ARTH Stock
- News Arch Therapeutics, Inc.
- Arch Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt